Cargando…
First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193159/ https://www.ncbi.nlm.nih.gov/pubmed/34115170 http://dx.doi.org/10.1007/s00415-021-10648-w |
_version_ | 1783706197070708736 |
---|---|
author | Havla, Joachim Schultz, Yannick Zimmermann, Hanna Hohlfeld, Reinhard Danek, Adrian Kümpfel, Tania |
author_facet | Havla, Joachim Schultz, Yannick Zimmermann, Hanna Hohlfeld, Reinhard Danek, Adrian Kümpfel, Tania |
author_sort | Havla, Joachim |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8193159 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-81931592021-06-11 First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine Havla, Joachim Schultz, Yannick Zimmermann, Hanna Hohlfeld, Reinhard Danek, Adrian Kümpfel, Tania J Neurol Letter to the Editors Springer Berlin Heidelberg 2021-06-11 2022 /pmc/articles/PMC8193159/ /pubmed/34115170 http://dx.doi.org/10.1007/s00415-021-10648-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Letter to the Editors Havla, Joachim Schultz, Yannick Zimmermann, Hanna Hohlfeld, Reinhard Danek, Adrian Kümpfel, Tania First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine |
title | First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine |
title_full | First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine |
title_fullStr | First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine |
title_full_unstemmed | First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine |
title_short | First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine |
title_sort | first manifestation of multiple sclerosis after immunization with the pfizer-biontech covid-19 vaccine |
topic | Letter to the Editors |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193159/ https://www.ncbi.nlm.nih.gov/pubmed/34115170 http://dx.doi.org/10.1007/s00415-021-10648-w |
work_keys_str_mv | AT havlajoachim firstmanifestationofmultiplesclerosisafterimmunizationwiththepfizerbiontechcovid19vaccine AT schultzyannick firstmanifestationofmultiplesclerosisafterimmunizationwiththepfizerbiontechcovid19vaccine AT zimmermannhanna firstmanifestationofmultiplesclerosisafterimmunizationwiththepfizerbiontechcovid19vaccine AT hohlfeldreinhard firstmanifestationofmultiplesclerosisafterimmunizationwiththepfizerbiontechcovid19vaccine AT danekadrian firstmanifestationofmultiplesclerosisafterimmunizationwiththepfizerbiontechcovid19vaccine AT kumpfeltania firstmanifestationofmultiplesclerosisafterimmunizationwiththepfizerbiontechcovid19vaccine |